Why the study?
A new version of the atrial fibrillation management guideline is needed due to increasing prevalence and recent research into stroke prevention.
Provides updated guidelines for the management of atrial fibrillation, with a focus on stroke prevention.
Answers are grounded in this paper and cite their sources.
Updates AF stroke prevention recommendations now; extends prior guidelines with integrated recent evidence.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population. Over 6 million Europeans suffer from this arrhythmia, and its prevalence is estimated to at least double in the next 50 years as the population ages. It is now 4 years since the last AF guideline was published, and a new version is now needed. AF confers a 5-fold risk of stroke, and one in five of all strokes is attributed to this arrhythmia. Ischaemic strokes in association with AF are often fatal, and those patients who survive are left more disabled by their stroke and more likely to suffer a recurrence than patients with other causes of stroke. In consequence, the risk of death from AF-related stroke is doubled and the cost of care is increased 1.5-fold. There has been much research into stroke prevention, which has influenced this guideline.
No takes yet. Share an insight, caveat, or question.
A 2011 study conducted a review in Atrial fibrillation. Atrial fibrillation confers a 5-fold risk of stroke, doubling the risk of death from stroke and increasing the cost of care 1.5-fold, necessitating updated management guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: